Kobo Biotech shareholding pattern

KOBO

2.75

0.16 (6.18%)
Last updated on 1 Feb, 2026 | 15:00 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Kobo Biotech Shareholding Pattern

  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
Total Promoters
Segment
Percent

Total Promoters

44.95%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0.66%

Retail

54.39%

Others

0%

Total Promoters
MAR '24
44.95%

Summary

For Year 2025-26, Kobo Biotech reports the following shareholding: Total Promoters at 44.95%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0.66%, and Retail at 54.39%. This breakdown provides a quick snapshot of ownership distribution for Kobo Biotech in 2025-26.

Kobo Biotech FAQs

As of 02-2026, the promoter shareholding in Kobo Biotech stands at 44.95% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Kobo Biotech is 0% and 0.66% respectively.

The retail shareholding of the Kobo Biotech is 54.39%.

Changes in shareholding patterns of Kobo Biotech can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Kobo Biotech are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.